151 related articles for article (PubMed ID: 18372518)
1. CD44 expression in metastatic and non-metastatic non-small cell lung cancers.
Kargi HA; Kuyucuoğlu MF; Alakavuklar M; Akpinar O; Erk S
Cancer Lett; 1997 Oct; 119(1):27-30. PubMed ID: 18372518
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
3. High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers.
Kondo K; Miyoshi T; Hino N; Shimizu E; Masuda N; Takada M; Uyama T; Monden Y
J Surg Oncol; 1998 Nov; 69(3):128-36. PubMed ID: 9846498
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CD44s expression in resected non-small cell lung cancer.
Ko YH; Won HS; Jeon EK; Hong SH; Roh SY; Hong YS; Byun JH; Jung CK; Kang JH
BMC Cancer; 2011 Aug; 11():340. PubMed ID: 21819617
[TBL] [Abstract][Full Text] [Related]
5. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors.
Afify AM; Tate S; Durbin-Johnson B; Rocke DM; Konia T
Int J Biol Markers; 2011; 26(1):50-7. PubMed ID: 21279958
[TBL] [Abstract][Full Text] [Related]
7. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
8. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
9. Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicity.
Takahashi K; Takahashi F; Hirama M; Tanabe KK; Fukuchi Y
Lung Cancer; 2003 Aug; 41(2):145-53. PubMed ID: 12871777
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas.
Sasaki JI; Tanabe KK; Takahashi K; Okamoto I; Fujimoto H; Matsumoto M; Suga M; Ando M; Saya H
Int J Oncol; 1998 Mar; 12(3):525-33. PubMed ID: 9472088
[TBL] [Abstract][Full Text] [Related]
11. The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma.
Kunimura T; Yoshida T; Sugiyama T; Morohoshi T
J Gastrointest Cancer; 2009; 40(3-4):115-8. PubMed ID: 19937401
[TBL] [Abstract][Full Text] [Related]
12. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
14. Variant expression of CD44 in preneoplastic lesions of the lung.
Wimmel A; Kogan E; Ramaswamy A; Schuermann M
Cancer; 2001 Sep; 92(5):1231-6. PubMed ID: 11571737
[TBL] [Abstract][Full Text] [Related]
15. CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva.
Rodríguez-Rodríguez L; Sancho-Torres I; Gibbon DG; Watelet LF; Mesonero C
J Soc Gynecol Investig; 2000; 7(1):70-5. PubMed ID: 10732319
[TBL] [Abstract][Full Text] [Related]
16. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
17. CD44 isoform expression in synovial sarcoma correlates with epitheliogenesis but not prognosis.
Sneath RJ; Mangham DC
Histopathology; 2000 Aug; 37(2):166-74. PubMed ID: 10931241
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 splice variants in human primary brain tumors.
Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.
Bourrguignon LY; Iida N; Welsh CF; Zhu D; Krongrad A; Pasquale D
J Neurooncol; 1995 Dec; 26(3):201-8. PubMed ID: 8750186
[TBL] [Abstract][Full Text] [Related]
20. CD44 splice variant expression in clear cell carcinoma of the ovary.
Rodríguez-Rodríguez L; Sancho-Torres I; Leakey P; Gibbon DG; Comerci JT; Ludlow JW; Mesonero C
Gynecol Oncol; 1998 Nov; 71(2):223-9. PubMed ID: 9826464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
